Skip to content

Comparative Effect of Box Breathing And Buteyko Breathing on Pulmonary Functions in Asthma

Comparative Effect of Box Breathing And Buteyko Breathing on Pulmonary Functions in Asthma

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07140458
Enrollment
36
Registered
2025-08-24
Start date
2024-12-17
Completion date
2025-07-02
Last updated
2025-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma (Diagnosis), Breathing Exercises

Keywords

Asthma, Breathing Exercise, Buteyko Breathing, Box Breathing, Pulmonary Function tests

Brief summary

The aim of this study was to evaluate the Effectiveness of Box Breathing Technique and Buteyko breathing techniques in patients with Asthma, using both Clinical Pulmonary tests as well as Patient reported outcomes.

Interventions

Buteyko Breathing is a technique focusing on controlled, reduced breathing to improve oxygen uptake and reduce hyperventilation-related symptoms using Air hunger. Procedure:- After gaining proper relaxation: 1. Exhale slowly, and then hold that breath. 2. Use the index finger and thumb to plug the nose. 3. Hold that breath until there is an urge to breathe, and then inhale. 4. Breathe normally for at least 10 seconds. 5. Repeat several times.

Box Breathing (4-4-4-4 Technique) - Box Breathing exercises boosts lung function by optimizing oxygen flow and activating relaxation responses.Each exercise Sessions included 20 cycles of Box Breathing. The procedure of the box breathing cycle includes: 1. inhale for 4 seconds 2. Hold the breath for 4 seconds 3. Exhale for 4 seconds 4. Hold the breath for 4 seconds, and repeat.

Sponsors

Riphah International University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
25 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subjects with bronchial asthma for more than one year * Subjects who are on regular treatment (both inhalers and medication). * Subjects who are conscious and cooperative.

Exclusion criteria

* Subject with recent abdominal, thoracic surgery. * Subject with any Disability; Physical or Mental. * Subjects who have other chronic respiratory diseases, new or current smoker, and had respiratory tract infection.

Design outcomes

Primary

MeasureTime frameDescription
Lung Function tests (FVC)through study completion, approximately 8 weeksChanges from Baseline, Lung function tests measure how well the lungs take in, hold, and move air, as well as how efficiently they transfer oxygen into the blood. These tests help diagnose and monitor respiratory diseases like asthma, COPD, pulmonary fibrosis, and restrictive lung diseases. Tets measures are compared against Normal value i.e: FVC ≥80%.
Lung Function Test (FEV¹)through study completion, approximately 8 weeksChanges from Baseline, Lung function tests measure how well the lungs take in, hold, and move air, as well as how efficiently they transfer oxygen into the blood. These tests help diagnose and monitor respiratory diseases like asthma, COPD, pulmonary fibrosis, and restrictive lung diseases. Test measures are compared against Normal value i.e: FEV¹ ≥80%.
Lung Function test (FEV₁/FVC ratio)through study completion, approximately 8 weeksChanges from Baseline, Lung function tests measure how well the lungs take in, hold, and move air, as well as how efficiently they transfer oxygen into the blood. These tests help diagnose and monitor respiratory diseases like asthma, COPD, pulmonary fibrosis, and restrictive lung diseases. Test measures are compared against Normal value i.e: FEV₁/FVC ≥0.7.

Secondary

MeasureTime frameDescription
Modified Borg Dyspnea Scalethrough study completion, approximately 8 weeksThe Modified Borg Dyspnea Scale (MBS) is a subjective tool used to measure a patient's perceived breathlessness (dyspnea) during physical activity or at rest. Scoring System: -Scale Range: 0 to 10(with verbal descriptors for each level). Higher values signify worse condition (Maximal effort).
Mcgill quality of life questionnairethrough study completion, approximately 8 weeksThe MQOL is a validated tool designed to assess the quality of life (QoL) in patients with life-threatening or chronic illnesses. It focuses on \*physical, psychological, existential, and social well-being\*. Response Scale: Most items use a 0-10 numerical rating scale (higher = better QoL). * 0 = Worst possible experience * 10= Best possible experience Overall Higher scores indicate better quality of life. Whereas Lower scores suggest significant distress in a domain (e.g., pain, existential crisis).

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026